Lanus Lab Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-06-2024
- Paid Up Capital ₹ 0.10 M
as on 26-06-2024
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.60 M
as on 26-06-2024
- Revenue -33.19%
(FY 2022)
- Profit 3.08%
(FY 2022)
- Ebitda -923.42%
(FY 2022)
- Net Worth -98.11%
(FY 2022)
- Total Assets -14.94%
(FY 2022)
About Lanus Lab
The Corporate was formerly known as Laa-Sun Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.60 M.
Sameer Kadam, Lata Kadam, Sudhirchandra Kadam, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239MH2009PTC189295
- Company No.
189295
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Auranagabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lanus Lab?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhirchandra Kadam  | Managing Director | 02-Jan-2009 | Current |
| Ankushkumar Kadam | Managing Director | 02-Jan-2009 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sameer Kadam | Director | 01-May-2014 | Current |
| Lata Kadam | Director | 25-Nov-2014 | Current |
| Archana Kadam | Director | 25-Nov-2014 | Current |
Financial Performance of Lanus Lab.
Lanus Lab Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 33.19% decrease. The company also saw a slight improvement in profitability, with a 3.08% increase in profit. The company's net worth observed a substantial decline by a decrease of 98.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lanus Lab?
In 2020, Lanus Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Texas Lifestyle Furniture Private LimitedActive 33 years 5 monthsAnkushkumar Kadam is a mutual person
- Durga Medical Foundation (Dmf) Private LimitedActive 36 years 4 months
Lata Kadam and Archana Kadam are mutual person
- Lanus Pharmaceuticals LimitedActive 6 months 2 days
Lata Kadam and Sudhirchandra Kadam are mutual person
- R.N. Wellness Private LimitedActive 14 years 21 days
Lata Kadam and Sudhirchandra Kadam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 24 Jun 2011 | ₹0.60 M | Open |
How Many Employees Work at Lanus Lab?
Unlock and access historical data on people associated with Lanus Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lanus Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lanus Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
